PG
LLY icon

Prostatis Group’s Eli Lilly LLY Stock Holding History

Prostatis Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$385K Buy
419
+83
+25% +$84.1K 0.1% 116
2025
Q4 		$361K Sell
336
-42
-11% -$40.2K 0.09% 121
2025
Q3 		$288K Buy
378
+47
+14% +$35K 0.07% 133
2025
Q2 		$258K Sell
331
-12
-3% -$9.32K 0.07% 130
2025
Q1 		$283K Sell
343
-13
-4% -$10.8K 0.09% 125
2024
Q4 		$275K Buy
+356
New +$295K 0.08% 133
2023
Q3 		– Sell
-52,057
Closed -$52.1K – 178
2023
Q2 		$52.1K Buy
+52,057
New +$21.8M 0.02% 175

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Prostatis Group's LLY Position: Q1 2026 in Review

Prostatis Group increased its Eli Lilly (LLY) stake by 25% in Q1 2026, buying an estimated $84.1K and bringing the position to 419 shares worth $385K. The position accounts for 0.1% of the portfolio, ranked #116.

Prostatis Group first reported a position in LLY in Q2 2023 and has held it in 7 quarters since. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Prostatis Group held 419 shares of Eli Lilly worth $385K as of Q1 2026.
  • Prostatis Group bought 83 Eli Lilly shares in Q1 2026, an estimated $84.1K.
  • Eli Lilly made up 0.1% of Prostatis Group's portfolio in Q1 2026, its #116 holding.
  • Prostatis Group first reported a position in Eli Lilly in Q2 2023 and has held it in 7 quarters since.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.